Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study

BACKGROUND: Inhaled corticosteroid/long-acting β(2)-agonist combinations (ICS/LABA) have emerged as first line therapies for chronic obstructive pulmonary disease (COPD) patients with exacerbation history. No randomized clinical trial has compared exacerbation rates among COPD patients receiving bud...

Descripción completa

Detalles Bibliográficos
Autores principales: Kern, David M, Davis, Jill, Williams, Setareh A, Tunceli, Ozgur, Wu, Bingcao, Hollis, Sally, Strange, Charlie, Trudo, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409772/
https://www.ncbi.nlm.nih.gov/pubmed/25899176
http://dx.doi.org/10.1186/s12931-015-0210-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409772/
https://www.ncbi.nlm.nih.gov/pubmed/25899176
http://dx.doi.org/10.1186/s12931-015-0210-x

Ejemplares similares